PB1796: ADMINISTRATION OF A KETOGENIC DIET FOR CHEMOTHERAPY PROTECTION IN ACUTE LEUKEMIA PATIENTS: IS IT FEASIBLE, SAFE, AND VALUABLE? PRELIMINARY RESULTS OF THE RANDOMIZED CONTROL...

por Cagigas, Maria Lastra, Rajakumar, Gayathiri, Skarratt, Kristen, Hayward, Rachael, Pelaia, Tiana, Ardjmand, Alireza, Vaughan, Lachlin, Fontana, Luigi, Fuller, Stephen
Publicado 2023

Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and C...

por van der Linde, Riana, Gatt, Prudence N., Smith, Sandy, Fernandez, Marian A., Vaughan, Lachlin, Blyth, Emily, Curnow, Jennifer, Brown, David A., Tegg, Elizabeth, Sasson, Sarah C.
Publicado 2023

Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy

por Schnegg-Kaufmann, Annatina S., Thoms, Julie A. I., Bhuyan, Golam Sarower, Hampton, Henry R., Vaughan, Lachlin, Rutherford, Kayleigh, Kakadia, Purvi M., Lee, Hui Mei, Johansson, Emma M. V., Failes, Timothy W., Arndt, Greg M., Koval, Jason, Lindeman, Robert, Warburton, Pauline, Rodriguez-Meira, Alba, Mead, Adam J., Unnikrishnan, Ashwin, Davidson, Sarah, Polizzotto, Mark N., Hertzberg, Mark, Papaemmanuil, Elli, Bohlander, Stefan K., Faridani, Omid R., Jolly, Christopher J., Zanini, Fabio, Pimanda, John E.
Publicado 2023